Total Payments
$2,811
2024 Payments
$125.00
Companies
14
Transactions
81
Payment Breakdown by Category
Food & Beverage$2,764 (98.3%)
Education$46.91 (1.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,764 | 80 | 98.3% |
| Education | $46.91 | 1 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,129 | 22 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $743.40 | 22 | $0 (2023) |
| ITI, Inc. | $267.74 | 9 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $265.69 | 7 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $127.23 | 6 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $73.16 | 4 | $0 (2023) |
| Alkermes, Inc. | $40.00 | 3 | $0 (2022) |
| Lundbeck LLC | $34.05 | 1 | $0 (2022) |
| EISAI INC. | $29.85 | 2 | $0 (2022) |
| Axsome Therapeutics, Inc. | $29.55 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $125.00 | 1 | ABBVIE INC. ($125.00) |
| 2023 | $651.37 | 18 | ABBVIE INC. ($414.95) |
| 2022 | $940.39 | 33 | ABBVIE INC. ($482.35) |
| 2021 | $827.65 | 26 | Neurocrine Biosciences, Inc. ($354.73) |
| 2020 | $141.93 | 2 | Neurocrine Biosciences, Inc. ($141.93) |
| 2019 | $124.27 | 1 | Neurocrine Biosciences, Inc. ($124.27) |
All Payment Transactions
81 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $30.66 | General |
| Category: Neuroscience | ||||||
| 05/04/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $109.65 | General |
| Category: NEUROSCIENCE | ||||||
| 03/21/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: NEUROSCIENCE | ||||||
| 03/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: NEUROSCIENCE | ||||||
| 03/01/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: PSYCHIATRY | ||||||
| 02/23/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Neuropsychiatry | ||||||
| 02/22/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 02/22/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2023 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $21.38 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 02/15/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $29.55 | General |
| Category: Psychology/Psychiatric | ||||||
| 02/14/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $96.20 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: PSYCHIATRY | ||||||
| 02/01/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: NEUROSCIENCE | ||||||
| 01/26/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Neuropsychiatry | ||||||
| 01/25/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Central Nervous System | ||||||
| 01/18/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: PSYCHIATRY | ||||||
| 09/14/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: Neuropsychiatry | ||||||
| 08/05/2022 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: BH | ||||||
| 07/27/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $117.65 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $29.64 | General |
| Category: Central Nervous System | ||||||
| 06/16/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: CNS | ||||||
| 06/15/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.14 | General |
| Category: NEUROSCIENCE | ||||||
About Dr. Christopher Galbick, DO
Dr. Christopher Galbick, DO is a Psychiatry healthcare provider based in Tigard, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2019. The National Provider Identifier (NPI) number assigned to this provider is 1184185423.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Galbick, DO has received a total of $2,811 in payments from pharmaceutical and medical device companies, with $125.00 received in 2024. These payments were reported across 81 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($2,764).
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry
- Location Tigard, OR
- Active Since 03/28/2019
- Last Updated 09/04/2024
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1184185423
Products in Payments
- VRAYLAR (Drug) $1,057
- INGREZZA (Drug) $743.40
- CAPLYTA (Drug) $267.74
- AUSTEDO (Drug) $265.69
- REXULTI (Drug) $115.66
- ABILIFY MAINTENA (Drug) $45.62
- SPRAVATO (Drug) $44.90
- ARISTADA (Drug) $40.00
- Dayvigo (Drug) $29.85
- Auvelity (Drug) $29.55
- INVEGA SUSTENNA (Drug) $28.26
- Azstarys (Drug) $22.45
- JORNAY PM (Drug) $21.38
- GRALISE (Drug) $14.32
- PERSERIS (Drug) $13.27
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.